Laddar...
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist
Gastrin releasing-peptide (GRP) is a potent growth factor in many malignancies. Benign prostatic hyperplasia (BPH) is a progressive age-related proliferation of glandular and stromal tissues; various growth factors and inflammatory processes are involved in its pathogenesis. We have demonstrated tha...
Sparad:
Huvudupphovsmän: | , , , , , , , , , , , , |
---|---|
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
National Academy of Sciences
2013
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3574942/ https://ncbi.nlm.nih.gov/pubmed/23359692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1222355110 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|